LSTA
LISATA THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.70
−2.30%Margins
Gross margin
95.0%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-177.4%
Return on equity
-132.6%
Return on assets
-199.3%
Return on invested capital
0.01x
Asset turnover
-$12.3M
Cash from operations
$0.97
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026